Entrada Therapeutics (TRDA) Metrics: History & Chart

Entrada Therapeutics, Inc.(TRDA)

Biotechnology · Boston, MA

$5.43-0.05 (-0.91%)

Delayed quote: Oct 6, 2026, 3:45 PM EDT

About Entrada Therapeutics, Inc.

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches. Its foremost product candidate, ENTR-601-44, is currently undergoing preclinical assessment for its potential in addressing both Duchenne muscular dystrophy and myotonic dystrophy type 1. Furthermore, Entrada is actively developing EEV-PMO-CAG, also targeting myotonic dystrophy type 1. Incorporated in 2016, the firm was formerly known as CycloPorters, Inc., before officially changing its name to Entrada Therapeutics, Inc. in October 2017. The company maintains its corporate headquarters in Boston, Massachusetts.

Boston, MA

152 employees

www.entradatx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Dipal Doshi

View full financials

Third-Party DCF Estimate (FMP)	$8.25
Price Gap vs Third-Party Estimate	+54.84%

7D Total Return	-11.90%
30D Total Return	-23.14%
YTD Total Return	-46.69%
1Y Total Return	-8.67%
3Y Total Return	-62.47%
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-46.69%
2025	-40.54%
2024	+14.58%
2023	+11.61%
2022	-21.03%
2021	N/A

CAGR TTM	-8.63%
CAGR 3Y	-27.86%
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	7.38
PE Ratio Avg TTM	7.70
PE Ratio Avg 3Y	8.44
Current VS TTM Avg	-4.15%
Current VS 3Y Avg	-12.56%
Current VS 5Y Avg	-12.56%

All Metrics

TRDA Valuation Metrics

TRDA Stock Price Metrics

TRDA Dividend Metrics

TRDA Growth Rate Metrics

TRDA Discounted Cash Flow Metrics

TRDA Returns By Period

TRDA Yearly Returns

TRDA Average Annual Returns By Period (CAGR)

TRDA Revenue Metrics

TRDA PE Ratio Metrics

TRDA PS Ratio Metrics

TRDA PB Ratio Metrics

TRDA Price to Free Cash Flow Ratio Metrics

TRDA Debt to Equity Ratio Metrics

TRDA PEG Ratio Metrics

TRDA FCF Yield

TRDA Earnings Yield

TRDA EBITDA Yield

TRDA OCF Yield

TRDA EV/EBIT Ratio Metrics

TRDA EV/EBITDA Ratio Metrics

TRDA EV/Assets Ratio Metrics

TRDA EV/Sales Ratio Metrics

TRDA Current Ratio Metrics

TRDA Quick Ratio Metrics

TRDA ROIC Metrics

TRDA Return on Assets Metrics

TRDA Return on Equity Metrics

TRDA Net Profit Margin Metrics

TRDA Gross Profit Margin Metrics

TRDA Tax Rate Metrics

PS Ratio	49.38
PS Ratio Avg TTM	28.94
PS Ratio Avg 3Y	4.04
Current VS TTM Avg	+70.62%
Current VS 3Y Avg	+1120.81%
Current VS 5Y Avg	+630.03%

PB Ratio	0.99
PB Ratio Avg TTM	1.22
PB Ratio Avg 3Y	1.41
Current VS TTM Avg	-18.58%
Current VS 3Y Avg	-29.84%
Current VS 5Y Avg	-35.26%

PFCF Ratio	3.45
PFCF Ratio Avg TTM	4.17
PFCF Ratio Avg 3Y	4.17
Current VS TTM Avg	-17.36%
Current VS 3Y Avg	-17.36%
Current VS 5Y Avg	-17.36%

Debt/Equity Ratio	0.21
Debt/Equity Ratio Avg TTM	0.17
Debt/Equity Ratio Avg 3Y	0.20
Current VS TTM Avg	+21.47%
Current VS 3Y Avg	+4.51%
Current VS 5Y Avg	+27.26%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	28.97%
FCF Yield Avg TTM	24.58%
FCF Yield Avg 3Y	24.58%
Current VS TTM Avg	+17.86%
Current VS 3Y Avg	+17.86%
Current VS 5Y Avg	+17.86%

Earnings Yield	13.55%
Earnings Yield Avg TTM	14.25%
Earnings Yield Avg 3Y	12.26%
Current VS TTM Avg	-4.91%
Current VS 3Y Avg	+10.52%
Current VS 5Y Avg	+10.52%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	56.85
Ev/Ebit Ratio Avg TTM	8.62
Ev/Ebit Ratio Avg 3Y	12.04
Current VS TTM Avg	+559.86%
Current VS 3Y Avg	+372.14%
Current VS 5Y Avg	+372.14%

Ev/Ebitda Ratio	29.59
Ev/Ebitda Ratio Avg TTM	12.21
Ev/Ebitda Ratio Avg 3Y	15.55
Current VS TTM Avg	+142.38%
Current VS 3Y Avg	+90.28%
Current VS 5Y Avg	+90.28%

Ev/Assets Ratio	0.60
Ev/Assets Ratio Avg TTM	0.90
Ev/Assets Ratio Avg 3Y	0.89
Current VS TTM Avg	-33.23%
Current VS 3Y Avg	-32.71%
Current VS 5Y Avg	-38.73%

Ev/Sales Ratio	38.55
Ev/Sales Ratio Avg TTM	25.48
Ev/Sales Ratio Avg 3Y	3.87
Current VS TTM Avg	+51.31%
Current VS 3Y Avg	+894.99%
Current VS 5Y Avg	+563.03%

Current Ratio	10.89
Current Ratio Avg TTM	14.01
Current Ratio Avg 3Y	9.65
Current VS TTM Avg	-22.27%
Current VS 3Y Avg	+12.81%
Current VS 5Y Avg	-4.56%

Quick Ratio	10.89
Quick Ratio Avg TTM	14.01
Quick Ratio Avg 3Y	9.65
Current VS TTM Avg	-22.27%
Current VS 3Y Avg	+12.81%
Current VS 5Y Avg	-4.56%

ROIC	(63.61%)
ROIC Avg 3Y	(16.00%)
ROIC Avg 5Y	(20.71%)
Current VS 3Y Avg	-297.55%
Current VS 5Y Avg	-207.17%
Current VS 10Y Avg	-179.18%

ROA	(55.47%)
ROA Avg TTM	(11.36%)
ROA Avg 3Y	(3.74%)
Current VS TTM Avg	-388.15%
Current VS 3Y Avg	-1383.33%
Current VS 5Y Avg	-984.07%

ROE	(71.02%)
ROE Avg TTM	(45.80%)
ROE Avg 3Y	(16.39%)
Current VS TTM Avg	-55.06%
Current VS 3Y Avg	-333.19%
Current VS 5Y Avg	-236.54%

Net Profit Margin	(3537.73%)
Net Profit Margin Avg TTM	(3452.18%)
Net Profit Margin Avg 3Y	(1338.50%)
Current VS TTM Avg	-2.48%
Current VS 3Y Avg	-164.30%
Current VS 5Y Avg	-33987.68%

Gross Profit Margin	83.89%
Gross Pft Margin Avg TTM	(407.39%)
Gross Pft Margin Avg 3Y	70.36%
Current VS TTM Avg	+120.59%
Current VS 3Y Avg	+19.23%
Current VS 5Y Avg	+96.73%

Tax Rate	4.77%
Tax Rate Avg 3Y	62.17%
Tax Rate Avg 5Y	62.17%
Current VS 3Y Avg	-92.32%
Current VS 5Y Avg	-92.32%
Current VS 10Y Avg	-92.32%